\"

Main Conference Day Two

9:00 AM - 9:45 AM KEYNOTE: Streamlining the Process: Maximize Usability and Minimize Costs from Compounds to Biologics

9:45 AM - 10:30 AM PANEL DISCUSSION: The Extension of Your Lab: Building Best-Practices for CRO Partnership

, , Elizabeth Admirand, Principle Research Associate, Lead Discovery, Epizyme

Elizabeth Admirand

Principle Research Associate, Lead Discovery
Epizyme

11:15 AM - 12:00 PM CASE STUDY: The Evolution of Compounds Management at AstraZeneca Boston

Jeff Andrews, Senior Research Scientist, AstraZeneca

Jeff Andrews

Senior Research Scientist
AstraZeneca

12:00 PM - 12:45 PM Blending Compound, Biological, and Clinical Sample Storage

1:45 PM - 2:30 PM Integrating Automation and a High-Performance Team within a Compound Management Environment

Jefferson Chin, Analytical Chemist/Lab Manager, Bristol-Myers Squibb

Jefferson Chin

Analytical Chemist/Lab Manager
Bristol-Myers Squibb

2:30 PM - 3:15 PM Fostering Pre-Competitive Partnerships with Big Pharma and Biobanks to Further Sequencing Efforts

8:00 AM - AM ROUNDTABLE DISCUSSIONS: Join the conversation with your peers on the hottest topics in the industry!

TABLE 1:

Leading Through Change and Organizational Restructuring
Discuss how to build a cohesive, agile team capable of performing during organizational shifts
Focus on the institutional knowledge, retention, ROI, and culture, of both contract staff and company staff


TABLE 2:

The Lab Of The Future
Employ principles of lean six sigma to assist in reducing non-value-added work from a process level—in lab design


TABLE 3:

Data Curation
How accurate is your data? Have you performed an audit?
Learn the true quality of your data—prior to upgrading your systems



4:30 PM - 5:15 PM Alliance, Collaborations and Due Diligence for CRO Efforts: Successful Integration into the Discovery Pipeline

Robert Hutchins, Research Scientist I, Bristol-Myers Squibb

Robert Hutchins

Research Scientist I
Bristol-Myers Squibb